|
1
|
Rdeini WM, Agbenorku P and Mitish VA:
Strategy of surgical management of peripheral neuropathy form of
diabetic foot syndrome in Ghana. Plast Surg Int.
2014:1850232014.PubMed/NCBI
|
|
2
|
Cakmak T, Metin S, Yaman H, Demirbas S,
Yildiz S, Turker T and Akin A: The effect of hyperbaric oxygen
therapy on ischemia-modified albumin levels in people with diabetes
with foot ulcers. Undersea Hyperb Med. 41:277–281. 2014.PubMed/NCBI
|
|
3
|
Zhang J, Guan M, Xie C, Luo X, Zhang Q and
Xue Y: Increased growth factors play a role in wound healing
promoted by noninvasive oxygen-ozone therapy in diabetic patients
with foot ulcers. Oxid Med Cell Longev. 2014:2734752014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thangarajah H, Vial IN, Grogan RH, Yao D,
Shi Y, Januszyk M, Galiano RD, Chang EI, Galvez MG, Glotzbach JP,
et al: HIF-1alpha dysfunction in diabetes. Cell Cycle. 9:75–79.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Madhyastha R, Madhyastha H, Pengjam Y,
Nakajima Y, Omura S and Maruyama M: NFkappaB activation is
essential for miR-21 induction by TGFβ1 in high glucose conditions.
Biochem Biophys Res Commun. 451:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Letelier P, García P, Leal P, Álvarez H,
Ili C, López J, Castillo J, Brebi P and Roa JC: miR-1 and miR-145
act as tumor suppressor microRNAs in gallbladder cancer. Int J Clin
Exp Pathol. 7:1849–1867. 2014.PubMed/NCBI
|
|
7
|
Wang YS, Li SH, Guo J, Mihic A, Wu J, Sun
L, Davis K, Weisel RD and Li RK: Role of miR-145 in cardiac
myofibroblast differentiation. J Mol Cell Cardiol. 66:94–105. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang S, Cui H, Xie N, Icyuz M, Banerjee S,
Antony VB, Abraham E, Thannickal VJ and Liu G: miR-145 regulates
myofibroblast differentiation and lung fibrosis. FASEB J.
27:2382–2391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Megiorni F, Cialfi S, Cimino G, De Biase
RV, Dominici C, Quattrucci S and Pizzuti A: Elevated levels of
miR-145 correlate with SMAD3 down-regulation in cystic fibrosis
patients. J Cyst Fibros. 12:797–802. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu WF, Wu WQ, Chen LQ, Yang WP and Wen H:
Analysis of the incidence of diabetic lower extremities vascular
disease, pathological changes and the related factors. J Pract Med.
26:2323–2325. 2010.
|
|
11
|
Hao D, Hu C, Zhang T, Feng G, Chai J and
Li T: Contribution of infection and peripheral artery disease to
severity of diabetic foot ulcers in Chinese patients. Int J Clin
Pract. 68:1161–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Janda K, Krzanowski M, Dumnicka P,
Kuśnierz-Cabala B, Kraśniak A and Sułowicz W: Transforming growth
factor beta 1 as a risk factor for cardiovascular diseases in
end-stage renal disease patients treated with peritoneal dialysis.
Clin Lab. 60:1163–1168. 2014.PubMed/NCBI
|
|
13
|
Cicha I, Yilmaz A, Klein M, Raithel D,
Brigstock DR, Daniel WG, Goppelt-Struebe M and Garlichs CD:
Connective tissue growth factor is overexpressed in complicated
atherosclerotic plaques and induces mononuclear cell chemotaxis in
vitro. Arterioscler Thromb Vasc Biol. 25:1008–1013. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng L, He X, Wang Y, Tang Y, Zheng C, Cai
H, Liu J, Wang Y, Fu Y and Yang GY: MicroRNA-210 overexpression
induces angiogenesis and neurogenesis in the normal adult mouse
brain. Gene Ther. 21:37–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanaan RA, Aldwaik M and Al-Hanbali OA:
The role of connective tissue growth factor in skeletal growth and
development. Med Sci Monit. 12:RA277–RA281. 2006.PubMed/NCBI
|
|
16
|
Hameedaldeen A, Liu J, Batres A, Graves GS
and Graves DT: FOXO1, TGF-β regulation and wound healing. Int J Mol
Sci. 15:16257–16269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okizaki S, Ito Y, Hosono K, Oba K, Ohkubo
H, Amano H, Shichiri M and Majima MS: Suppressed recruitment of
alternatively activated macrophages reduces TGF-β1 and impairs
wound healing in streptozotocin-induced diabetic mice. Biomed
Pharmacother. 70:317–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li
H and Du J: The Notch γ-secretase inhibitor ameliorates kidney
fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway
activation. Int J Biochem Cell Biol. 55:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Y, Ye K, Wu H, Sun Y, Shi H and Huo K:
Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting
with NLK. Mol Cell Biochem. 333:293–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin J, Jenkins RH, Bennagi R, Krupa A,
Phillips AO, Bowen T and Fraser DJ: Post-transcriptional regulation
of transforming growth factor beta-1 by microRNA-744. PLoS One.
6:e250442011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barshes NR, Gold B, Garcia A, Bechara CF,
Pisimisis G and Kougias P: Minor amputation and palliative wound
care as a strategy to avoid major amputation in patients with foot
infections and severe peripheral arterial disease. Int J Low Extrem
Wounds. 13:211–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
